Growing Organically and Inorganically
We maintain a Hold rating on HUMAN, with the new target price of Bt11.12/share (DCF, WACC at 8.6%, terminal growth rate at 2%). We project the...
85 Views
Earnings Growth Prospects Somewhat Priced In
We retain a positive view on HUMAN's earnings growth potential, boosted by organic and inorganic growth. While its outlook should continue to be...
83 Views
Hiccup in 2Q20E Earnings but Long-Term Outlook Intact
We maintain a Buy on HUMAN with the target price unchanged at Bt9.85/share. While the firm's 2Q20E earnings are expected to slow down QoQ as a...
85 Views